Search clinical trials for: 68-Gallium DOTATATE

Total 7172 results

Melanoma and Skin Cancer Trials Limited

Recruiting

Targeted Therapy and Avelumab in Merkel Cell Carcinoma (GoTHAM)

Metastatic Merkel Cell Carcinoma

Australia
Bayer

Withdrawn

Capadenoson in Angina Pectoris

Chronic Stable Angina

Italy, Hungary, Poland, Slovakia, Israel, Czech Republic
Ochsner Health System

Unknown

68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors

Neuroendocrine Tumor | Neuroendocrine Carcinoma | Carcinoid Tumor | Neuroendocrine Cancer | Carcinoid | Islet Cell Tumor | Neuroendocrine | Apudoma

United States
Emil Loldrup Fosbol

Recruiting

64Cu-DOTATATE PET-CT-skanning and Infective Endocarditis.

Endocarditis | Endocarditis;Chronic | Endocarditis Acute

Denmark
Curium US LLC

Approved for marketing

Copper Cu 64 Dotatate for the Detection, Localization and Monitoring of SSTR Expressing (NETs)

Neuroendocrine Tumors
Novartis Pharmaceuticals

Not yet recruiting

NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.

Metastatic Neuroendocrine Prostate Cancer
Advanced Accelerator Applications

Active, not recruiting

Italian Prospective Observational Study Assessing the Effectiveness and Outcomes Associated With Lutathera Treatment in GEP-NETs (REAL-LU)

Gastroenteropancreatic Neuroendocrine Tumor

Italy
Sue O'Dorisio
National Cancer Institute (NCI)

Completed

Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT

Neuroendocrine Tumor | Neuroblastoma | Somatostatinoma | Adult Medulloblastoma | Childhood Medulloblastoma

United States
Centre Leon Berard

Unknown

Feasibility Study of 68Ga-PSMA PET-CT and 18F-FDOPA PET-CT in Glioblastoma's Patients (PAraDiGM)

Glioblastomas

France
UMC Utrecht

Recruiting

68Ga PET/CT Versus 99mTc SPECT/CT for Lung Perfusion and Ventilation Scintigraphy; a Technical and Practical Feasibility Study (GaTcha)

Pulmonary Embolism | Ventilation Perfusion Mismatch

Netherlands
Chris Goss
Cystic Fibrosis Foundation

Recruiting

IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study) (ABATE)

Nontuberculous Mycobacterium Infection

United States
Royal Marsden NHS Foundation Trust

Completed

Simplification of Low Level Internal Dosimetry (SOLLID)

Exposure to Medical Diagnostic Radiation

United Kingdom
Suez Canal University

Completed

Evaluation of Antibacterial Effect of Allium Sativum, Calcium Hydroxide and Their Combination in Infected Mature Teeth (Garlic)

Drug Effect

Egypt
Aeras

Completed

Biological Samples Obtained by Leukapheresis Induced by Two BCG Vaccinations in BCG-naïve Healthy Adults in the US ((A-051))

Tuberculosis

United States
National Institute of Diabetes and Digestive and...
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome

Cushing's Syndrome | ACTH

United States
Novartis Pharmaceuticals

Active, not recruiting

LUTATHERA Injection General Use Result Survey

Somatostatin Receptor-positive Neuroendocrine Tumor

Japan
Advanced Accelerator Applications

Approved for marketing

EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx

Neuroendocrine Tumors

United States
Lund University Hospital

Completed

A Multicenter Study Evaluating Efficacy and Safety of 177Lu-DOTA-TATE Based on Kidney-Dosimetry in Patients With Disseminated Neuroendocrine Tumors (ILUMINET)

Neuroendocrine Tumors | Liver Metastases

Sweden
King Faisal Specialist Hospital & Research Center

Unknown

Treatment of Neuroendocrine Tumors (NETs) With Combination of Everolimus and Radiolabeled Somatostatin Analogue

Neuroendocrine Tumors

Saudi Arabia
Thomas Hope

Completed

Yttrium-90 DOTA-TOC Intra-arterial (IA) Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumor

Neuroendocrine Tumor

United States
Ass. Prof. Jan Nyman

Terminated

Phase II Randomized Study on Locally Advanced NSCLC Escalated Dose on Individual Basis Treatment With Radiochemotherapy (PLANET)

Non Small Cell Lung Cancer | Locally Advanced Disease

Sweden
Jules Bordet Institute

Withdrawn

Randomized Phase III of PRRT Versus Interferon (CASTOR)

Gastro-intestinal Neuroendocrine Tumors

Belgium
Andrei Iagaru
General Electric

Completed

68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate Cancer

Prostate Cancer

United States
Andrei Iagaru

Completed

68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer

Stage II Prostate Adenocarcinoma | Stage III Prostate Adenocarcinoma | Stage IV Prostate Adenocarcinoma

United States
University Hospital of North Norway

Completed

Can Vitamin D Supplementation Prevent Bone Loss in Persons With Multiple Sclerosis

Multiple Sclerosis, Osteoporosis

Norway
Providence Health & Services
Exelixis; Advanced Accelerator Applications SA

Active, not recruiting

Study of Cabozantinib With Lu-177 in Patients With Somatostatin Receptor 2 Positive Neuroendocrine Tumors

Neuroendocrine Tumors

United States
Stanford University

Not yet recruiting

68-Ga-FAPI PET Imaging in Malignancy

Cancer

United States
Taiho Pharmaceutical Co., Ltd.

Terminated

Orantinib In Combination With Transcatheter Arterial Chemoembolization In Patients With Unresectable Hepatocellular Carcinoma (ORIENTAL)

Hepatocellular Carcinoma

Korea, Republic of, Taiwan, Japan
AHS Cancer Control Alberta

Recruiting

A Trial to Assess the Safety and Effectiveness of Lutetium-177 Octreotate Therapy in Neuroendocrine Tumours

Carcinoma, Neuroendocrine

Canada
Lawson Health Research Institute

Active, not recruiting

An Open Label Registry Study of Lutetium-177 (DOTA0, TYR3) Octreotate (Lu-DOTA-TATE) Treatment in Patients With Somatostatin Receptor Positive Tumours

Neuroendocrine Carcinoma

Canada
SENAI CIMATEC
Hospital Espanhol

Completed

Clinical Study to Evaluate the Effect of Food Supplement in People Infected With Coronavirus

COVID-19 Virus Infection

Brazil
University of Washington
Cystic Fibrosis Foundation

Completed

A Pharmacokinetic and Safety Study of IV Gallium Nitrate (Ganite) in Cystic Fibrosis Patients

Cystic Fibrosis

United States
Celal Bayar University

Completed

The Role of 68GA DOTATATE PET/CT In Breast Cancer Imaging

Breast Cancer

Turkey
M.D. Anderson Cancer Center

Withdrawn

Poziotinib and Ramucirumab for the Treatment of EGFR Exon 20 Mutant Stage IV Non-small Cell Lung Cancer

Metastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8
Taiho Pharmaceutical Co., Ltd.

Completed

Phase I/II Study of TSU-68 for Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma

Japan
Weill Medical College of Cornell University
Merck Sharp & Dohme LLC; United States Department of Defense

Recruiting

Phase I/II Trial of Pembrolizumab and Androgen-receptor Pathway Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer

Prostate Cancer

United States
Medical College of Wisconsin

Recruiting

Oral Gallium Maltolate for the Treatment of Relapsed and Refractory Glioblastoma

Glioblastoma

United States
Rutgers, The State University of New Jersey
Radiological Society of North America

Unknown

Novel Gallium Imaging in Hepatocellular Carcinoma

Hepatocellular Carcinoma

United States
Sue O'Dorisio
Advanced Accelerator Applications

Withdrawn

Dosimetry Guided PRRT With 177Lu-DOTATATE in Children and Adolescents

Neuroendocrine Tumors | Pheochromocytoma | Paraganglioma

United States
Mayo Clinic

Completed

d68Ga-DOTATATE PET/CT Assessment of Cardiac Sarcoidosis

Cardiac Sarcoidosis

United States
Stanford University
National Cancer Institute (NCI)

Completed

68Ga-DOTA-Bombesin PET/MRI in Imaging Patients With Prostate Cancer

Prostate Carcinoma

United States
VL-Medi Oy
Merck Sharp & Dohme LLC

Unknown

Is Cerazette Use Before Nexplanon Insertion Predictive for Bleeding Pattern?

Bleeding

Finland
Emory University
National Cancer Institute (NCI); National Institutes of Health (NIH); Telix Pharmaceuticals...

Active, not recruiting

Fluciclovine F18 or Ga68-PSMA PET/CT to Enhance Prostate Cancer Outcomes

Prostate Adenocarcinoma

United States
Titan Pharmaceuticals

Terminated

Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies

Lymphoma | Prostatic Neoplasms | Multiple Myeloma | Bladder Neoplasms

United States
Peking University

Not yet recruiting

Phase II Study to Evaluate the Efficacy and Safety of 177Lu-Dotatate in the First-line Treatment of Patients With Locally Advanced or Metastatic, Somatostatin Receptor-positive G2 or G3 Gastroenteropancreatic Neuroendocrine Tumors

Neuroendocrine Tumors

China
University of Pennsylvania

Recruiting

Effects of the Contraceptive Implant in Women With Sickle Cell Disease (SCD CURE)

Sickle Cell Disease

United States
Nicholas Fidelman, MD
Merck Sharp & Dohme LLC; BTG International Inc.

Active, not recruiting

Pembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors and Liver Metastases

Neuroendocrine Neoplasm | Metastatic Malignant Neoplasm in the Liver

United States
Weill Medical College of Cornell University
Merck Sharp & Dohme LLC; Novartis; GI Research Foundation

Recruiting

Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer (iPRRT)

Merkel Cell Carcinoma

United States
Tine Gregersen, MD

Recruiting

Dosimetry Based PRRT Versus Standard Dose PRRT With Lu-177-DOTATOC in NEN Patients (DOBATOC)

Neuroendocrine Neoplasm

Denmark
Tel-Aviv Sourasky Medical Center

Unknown

The Potential Role of Ga-68-PSMA in Staging, Restaging and Monitoring Response in Primary Liver Cancer: Comparison With F-18-FDG

Hepatocellular Carcinoma (HCC)

Search clinical trials for: 68-Gallium DOTATATE

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burkina Faso

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations